Should I invest in kazia for the day

**Investing in KZIA for the day is not advisable** due to the following reasons:

1. **Recent Stock Performance**: Kazia Therapeutics (KZIA) has experienced a significant decline in its stock price, with a 26.41% drop on July 12, 2024. This recent volatility suggests that the stock may continue to be unpredictable in the short term.

2. **Technical Indicators**: The stock's technical indicators are not favorable for a day trade. The Relative Strength Index (RSI) is at 97.32, which is considered overbought and suggests that the stock may be due for a pullback. Additionally, the stock is trading above its 5-day and 10-day moving averages, which could indicate a bearish trend.

|Ticker|Name|RSI|Date|code|market_code|
|---|---|---|---|---|---|
|KZIA.O|Kazia Therapeutics|97.3171|20240711|KZIA|186|

3. **Lack of Positive Momentum**: There is no recent positive news or catalysts that would indicate a turnaround in the stock's performance. The decline in stock price is likely due to the market's reaction to the company's clinical trial results, which have already been factored into the stock's movement.
4. **Market Sentiment**: The heavy trading volume on the days of the announcement suggests that there may have been a speculative bubble surrounding the stock, which could have burst, leading to the current decline.

In conclusion, the combination of the recent significant drop in stock price, unfavorable technical indicators, lack of positive momentum, and potential speculative bubble burst make it unsuitable to invest in KZIA for day trading. Investors should exercise caution and consider these factors before making any investment decisions.